| dc.creator | Giormezis N., Doudoulakakis A., Tsilipounidaki K., Militsopoulou M., Kalogeras G., Stamouli V., Kolonitsiou F., Petinaki E., Lebessi E., Spiliopoulou I. | en |
| dc.date.accessioned | 2023-01-31T07:42:26Z | |
| dc.date.available | 2023-01-31T07:42:26Z | |
| dc.date.issued | 2021 | |
| dc.identifier | 10.1186/s12866-021-02272-5 | |
| dc.identifier.issn | 14712180 | |
| dc.identifier.uri | http://hdl.handle.net/11615/72410 | |
| dc.description.abstract | Background: Staphylococcus aureus causes various infections, including skin and soft tissue infections (SSTIs). In this study, methicillin-susceptible S. aureus (MSSA) from SSTIs among patients in three tertiary-care hospitals in Greece were studied in terms of antimicrobial resistance, clonal distribution, toxin and adhesin genes carriage. Results: During a five-year period (2014–2018), 6145 S. aureus were recovered from 13,244 patients with SSTIs and tested for antimicrobial susceptibility. MSSA were 4806 (78.21 %) including 1484 isolates with mupirocin minimum inhibitory concentration (MIC) > 64 mg/L (30.88 %). Two hundred and sixty representative mupirocin-resistant MSSA were analyzed for genes encoding Panton-Valentine leukocidin (PVL, lukS/lukF-PV), exfoliative toxins (eta, etb), adhesin FnbA (fnbA) and resistance genes mupA (high-level resistance to mupirocin), fusB (fusidic acid), aminoglycosides’ modifying enzymes, ermA, ermC and msrA (macrolides/lincosamides) by PCRs. Strains were classified into clones by PFGE and MLST. All mupirocin-resistant MSSA were penicillin-resistant; 92.7 % expressed resistance to fusidic acid and 88.9 % to tobramycin. All 260 molecularly analyzed isolates were mupA-positive; all fusidic acid-resistant (241/260) carried fusB whereas, the tobramycin-resistant ones (230), ant(4′)-Ia. The majority carried eta (93.85 %), etb (98.08 %) and fnbA (88.85 %). PFGE typing revealed a mostly unvarying population; 260 MSSA were grouped into three types. One major eta/etb-positive clone comprising of 258/260 strains (99.2 %), PFGE type 1, was classified as ST121, including nine strains co-carrying PVL. Another PVL-positive strain was identified as ST1, and one toxins-negative as ST21. Conclusions: A mupirocin-resistant MSSA clone, ST121, carrying resistance, exfoliative toxins and adhesin genes, was spread and predominated in SSTIs from patients in Greece during the five-year studied period. © 2021, The Author(s). | en |
| dc.language.iso | en | en |
| dc.source | BMC Microbiology | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109184173&doi=10.1186%2fs12866-021-02272-5&partnerID=40&md5=36367b9bad57f29820b62eb4ff97017e | |
| dc.subject | adhesin | en |
| dc.subject | aminoglycoside | en |
| dc.subject | ampicillin | en |
| dc.subject | cefoxitin | en |
| dc.subject | chloramphenicol | en |
| dc.subject | ciprofloxacin | en |
| dc.subject | clindamycin | en |
| dc.subject | cotrimoxazole | en |
| dc.subject | erythromycin | en |
| dc.subject | fosfomycin | en |
| dc.subject | fusidic acid | en |
| dc.subject | gentamicin | en |
| dc.subject | leukocidin | en |
| dc.subject | lincosamide | en |
| dc.subject | macrolide | en |
| dc.subject | nitrofurantoin | en |
| dc.subject | oxacillin | en |
| dc.subject | Panton Valentine leukocidin | en |
| dc.subject | penicillin derivative | en |
| dc.subject | pseudomonic acid | en |
| dc.subject | rifampicin | en |
| dc.subject | teicoplanin | en |
| dc.subject | tetracycline | en |
| dc.subject | timentin | en |
| dc.subject | tobramycin | en |
| dc.subject | vancomycin | en |
| dc.subject | antiinfective agent | en |
| dc.subject | bacterial toxin | en |
| dc.subject | exotoxin | en |
| dc.subject | meticillin | en |
| dc.subject | Panton-Valentine leukocidin | en |
| dc.subject | pseudomonic acid | en |
| dc.subject | antibiotic resistance | en |
| dc.subject | antibiotic sensitivity | en |
| dc.subject | antimicrobial therapy | en |
| dc.subject | Article | en |
| dc.subject | bacteremia | en |
| dc.subject | bacterial gene | en |
| dc.subject | bacterial virulence | en |
| dc.subject | bacterium isolate | en |
| dc.subject | disk diffusion | en |
| dc.subject | DNA extraction | en |
| dc.subject | gene frequency | en |
| dc.subject | gene locus | en |
| dc.subject | gene sequence | en |
| dc.subject | Greece | en |
| dc.subject | human | en |
| dc.subject | inhibitory concentration | en |
| dc.subject | methicillin susceptible Staphylococcus aureus | en |
| dc.subject | minimum inhibitory concentration | en |
| dc.subject | molecular epidemiology | en |
| dc.subject | molecular typing | en |
| dc.subject | motor unit potential | en |
| dc.subject | multilocus sequence typing | en |
| dc.subject | nonhuman | en |
| dc.subject | penicillin resistance | en |
| dc.subject | phylogenetic tree | en |
| dc.subject | polymerase chain reaction | en |
| dc.subject | pulsed field gel electrophoresis | en |
| dc.subject | serotyping | en |
| dc.subject | skin infection | en |
| dc.subject | soft tissue infection | en |
| dc.subject | Staphylococcus aureus | en |
| dc.subject | tertiary care center | en |
| dc.subject | adult | en |
| dc.subject | drug effect | en |
| dc.subject | genetics | en |
| dc.subject | Greece | en |
| dc.subject | isolation and purification | en |
| dc.subject | microbiology | en |
| dc.subject | soft tissue infection | en |
| dc.subject | staphylococcal skin infection | en |
| dc.subject | Staphylococcus infection | en |
| dc.subject | Adult | en |
| dc.subject | Anti-Bacterial Agents | en |
| dc.subject | Bacterial Toxins | en |
| dc.subject | Exotoxins | en |
| dc.subject | Genes, Bacterial | en |
| dc.subject | Greece | en |
| dc.subject | Humans | en |
| dc.subject | Leukocidins | en |
| dc.subject | Methicillin | en |
| dc.subject | Multilocus Sequence Typing | en |
| dc.subject | Mupirocin | en |
| dc.subject | Soft Tissue Infections | en |
| dc.subject | Staphylococcal Infections | en |
| dc.subject | Staphylococcal Skin Infections | en |
| dc.subject | Staphylococcus aureus | en |
| dc.subject | BioMed Central Ltd | en |
| dc.title | Emergence of a mupirocin-resistant, methicillin-susceptible Staphylococcus aureus clone associated with skin and soft tissue infections in Greece | en |
| dc.type | journalArticle | en |